Zepbound (Tirzepatide) Zepbound enhances weight loss by targeting both GLP-1 and GIP hormones, resulting in an average weight loss of 20.9% in clinical trials
Diabetes Care (2010) 33(2):42833.10.2337/dc09-1499 65 EganAGBlindEDunderKde GraeffPAHummerBTBourcierTet alPancreatic safety of incretin-based drugs FDA and EMA assessment
At baseline, mean age was 45 years (range 18 to 78), 79% were female, 85% were White, 10% were Black or African American, and 11% were Hispanic/Latino Ethnicity
AMPK, adenosine 5-monophosphate-activated protein kinase
Key nutritional considerations include: Protein intake: Prioritize lean proteins such as chicken, fish, eggs, legumes, and Greek yogurt at each meal to support hair follicle function